JP2023514606A5 - - Google Patents
Info
- Publication number
- JP2023514606A5 JP2023514606A5 JP2022549677A JP2022549677A JP2023514606A5 JP 2023514606 A5 JP2023514606 A5 JP 2023514606A5 JP 2022549677 A JP2022549677 A JP 2022549677A JP 2022549677 A JP2022549677 A JP 2022549677A JP 2023514606 A5 JP2023514606 A5 JP 2023514606A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- therapeutic agent
- less
- pharmaceutically acceptable
- nanoparticles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062978773P | 2020-02-19 | 2020-02-19 | |
| US62/978,773 | 2020-02-19 | ||
| PCT/US2021/018466 WO2021168043A1 (en) | 2020-02-19 | 2021-02-18 | Therapeutic agent nanoparticles and methods of preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023514606A JP2023514606A (ja) | 2023-04-06 |
| JP2023514606A5 true JP2023514606A5 (cg-RX-API-DMAC10.html) | 2024-02-27 |
| JP7756097B2 JP7756097B2 (ja) | 2025-10-17 |
Family
ID=77391611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022549677A Active JP7756097B2 (ja) | 2020-02-19 | 2021-02-18 | 治療剤ナノ粒子および調製方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12370145B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4106731A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7756097B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20220144378A (cg-RX-API-DMAC10.html) |
| CN (2) | CN115461043B (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021221987B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3166756A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL295268A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021168043A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022109076A1 (en) * | 2020-11-19 | 2022-05-27 | Nano Pharmasolutions, Inc. | Dry powder antiviral compositions and their use for treating viral infection |
| WO2023086903A1 (en) * | 2021-11-10 | 2023-05-19 | Nano Pharmasolutions, Inc. | Cannabidiol nanoparticle compositions |
| WO2025259725A1 (en) * | 2024-06-11 | 2025-12-18 | Nano Pharmasolutions, Inc. | Apomorphine compositions and therapeutic applications |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2350894C (en) * | 1998-11-18 | 2009-01-27 | University Of Florida | Methods for preparing coated drug particles and pharmaceutical formulations thereof |
| US6316029B1 (en) * | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
| WO2003103637A2 (en) * | 2002-01-10 | 2003-12-18 | Ranbaxy Laboratories Limited | Modified release, multiple unit drug delivery systems |
| KR100644219B1 (ko) | 2004-09-16 | 2006-11-10 | 주식회사 피앤아이 | 나노 입자의 형성방법, 그의 장치 및 그의 응용제품 |
| RU2008142388A (ru) * | 2006-04-03 | 2010-05-10 | Тева Фармасьютикл Индастриес Лтд. (Il) | Микрочастицы лекарственного вещества |
| WO2008045022A2 (en) | 2006-08-09 | 2008-04-17 | Luna Innovations Incorporated | Additive particles having superhydrophobic characteristics and coatings and methods of making and using the same |
| EP2050437A1 (en) * | 2007-10-15 | 2009-04-22 | Laboratoires SMB | Improved pharmaceutical dry powder compositions for inhalation. |
| EP2170289B1 (en) * | 2008-03-25 | 2012-02-15 | Formac Pharmaceuticals N.v. | Preparation method for solid disupersions |
| TW201311234A (zh) | 2011-04-28 | 2013-03-16 | Ajinomoto Kk | 抗癌劑副作用改善用組成物 |
| MX351059B (es) * | 2012-08-17 | 2017-09-29 | Laboratorios Senosiain S A De C V Star | Composicion farmaceutica oral en forma de microesferas y proceso de elaboracion. |
| US9801820B2 (en) | 2012-11-12 | 2017-10-31 | New Jersey Institute Of Technology | Pharmaceutical core-shell composite powder and processes for making the same |
| US10030292B2 (en) | 2014-05-26 | 2018-07-24 | Hrl Laboratories, Llc | Hydride-coated microparticles and methods for making the same |
| GB201506381D0 (en) | 2015-04-15 | 2015-05-27 | Isis Innovation | Embolization particle |
-
2021
- 2021-02-18 JP JP2022549677A patent/JP7756097B2/ja active Active
- 2021-02-18 AU AU2021221987A patent/AU2021221987B2/en active Active
- 2021-02-18 KR KR1020227030211A patent/KR20220144378A/ko active Pending
- 2021-02-18 WO PCT/US2021/018466 patent/WO2021168043A1/en not_active Ceased
- 2021-02-18 EP EP21757524.0A patent/EP4106731A4/en active Pending
- 2021-02-18 CN CN202180029355.1A patent/CN115461043B/zh active Active
- 2021-02-18 CA CA3166756A patent/CA3166756A1/en active Pending
- 2021-02-18 IL IL295268A patent/IL295268A/en unknown
- 2021-02-18 CN CN202411160615.0A patent/CN119345135A/zh active Pending
- 2021-02-18 US US17/178,456 patent/US12370145B2/en active Active
-
2023
- 2023-05-24 US US18/322,693 patent/US12616659B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7042015B2 (ja) | 経口投与型コルチコステロイド組成物 | |
| CA2658521C (en) | Enhanced immediate release formulations of topiramate | |
| CN104203284B (zh) | 吸入用吡咯衍生物干粉制剂 | |
| ES2312308T1 (es) | Formulaciones de liberacion sostenida de topiramato. | |
| WO2009050726A2 (en) | Compositions and methods for improved delivery of bupropion | |
| JP2011052021A (ja) | 鼻腔送達用医薬品組成物 | |
| TWI849062B (zh) | 保存水性懸浮液中以無溶劑混合方法製備的功能性塗覆之活性醫藥成份微粒 | |
| TWI286942B (en) | Rapidly disintegrating tablet and preparing method thereof | |
| JP2024543125A5 (cg-RX-API-DMAC10.html) | ||
| CN117580803A (zh) | 用于药物递送的硅颗粒 | |
| CN115969858A (zh) | 药物组合物及其制备方法和用于治疗冠状病毒引起的疾病的用途 | |
| KR102363727B1 (ko) | 생체이용률이 개선된 프란루카스트 함유 고형 제제의 조성물 및 그 제조방법 | |
| CN106999429B (zh) | 纳米悬浮剂制剂 | |
| CN107427462B (zh) | 固态分散体 | |
| JP2015071542A (ja) | 固体分散体の製造方法 | |
| US20260000683A1 (en) | Sustained-release injectable composition containing dutasteride | |
| JPWO2010119851A1 (ja) | 口腔内崩壊錠 | |
| EP4313155A1 (fr) | Formulation par voie orale d'ivermectine et utilisations | |
| JP2023526098A5 (cg-RX-API-DMAC10.html) | ||
| Deepika et al. | A review on orally disintegrating tablets | |
| WO2018091148A1 (en) | Pharmaceutical composition comprising an antiemetic agent and method for the preparation thereof | |
| Khalafi et al. | A REVIEW on FAST DISSOLVING DRUG DELIVERY SYSTEM: TAKING ADVANTAGE of NANOFIBERS | |
| KR20140094762A (ko) | 나프로닐을 포함하는 고체 분산체 및 이의 제조방법 |